Martín Lázaro-Quintela

9PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRegenerative medicine (incl. stem cells)Medicine, nursing and health curriculum and pedagogyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 10, 2026
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

Belén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre

|Jan 15, 2026
Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non-Small Cell Lung Cancer.

Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal

|Sep 12, 2024
Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancer.

Ovidio Fernández Calvo, José Muñoz Iglesias, Estephany Abou Jokh Casas

|Feb 21, 2023
Correction: Personalized Precision Medicine for Health Care Professionals: Development of a Competency Framework.

Fernando Martin-Sanchez, Martín Lázaro, Carlos López-Otín

|Feb 07, 2023
Personalized Precision Medicine for Health Care Professionals: Development of a Competency Framework.

Fernando Martin-Sanchez, Martín Lázaro, Carlos López-Otín

|Sep 28, 2022
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Marta Casarrubios, Mariano Provencio, Ernest Nadal

Pageof 2

Frequent Collaborators

4 joint publications

Virginia Calvo

4 joint publications

Alberto Cruz-Bermúdez

4 joint publications

Ernest Nadal

4 joint publications

Amelia Insa Molla